Les douleurs dans la sclérose en plaques

Foley PL, Vesterinen HM, Laird BJ, et al (2013) Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis. Pain 154:632–42

Brochet B, Deloire MS, Ouallet JC, et al (2009) Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2- year longitudinal study. Clin J Pain 25:211–7

Moisset X, Ouchchane L, Guy N, et al (2013) Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain 154:2691–9

Grasso MG, Clemenzi A, Tonini A, et al (2008) Pain in multiple sclerosis: a clinical and instrumental approach.Mult Scler 14:506–13

Yamout B, Issa Z, Herlopian A, et al (2013) Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis. Eur J Neurol 20:756–64

Piwko C, Desjardins OB, Bereza BG, et al (2007) Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada. Pain Res Manag 12:259–65

O’Connor AB, Schwid SR, Herrmann DN, et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137:96–111

Truini A, Barbanti P, Pozzilli C, Cruccu G (2012) A mechanismbased classification of pain in multiple sclerosis. J Neurol 260:351–67

Svendsen KB, Jensen TS, Overvad K, et al (2003) Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 60:1089–94

Heitmann H, Biberacher V, Tiemann L, et al (2016) Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler 22:1224–30

Bouhassira D, Lantéri-Minet M, Attal N, et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–7

Agostoni E, Frigerio R, Protti A (2005) Controversies in optic neuritis pain diagnosis. Neurol Sci 26(Suppl 2):s75–s78

D’Amico D, La Mantia L, Rigamonti A, et al (2004) Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 24:980–4

Nicoletti A, Patti F, Lo Fermo S, et al (2008) Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia 28:1163–9

Putzki N, Pfriem A, Limmroth V, et al (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16:262–7

Pakpoor J, Handel AE, Giovannoni G, et al (2012) Meta-analysis of the relationship between multiple sclerosis and migraine. PloS One 7:e45295

Gee JR, Chang J, Dublin AB, Vijayan N (2005) The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 45:670–7

Zorzon M, Zivadinov R, Nasuelli D, et al (2003) Risk factors of multiple sclerosis: a case-control study. Neurol Sci 24:242–7

Kister I, Munger KL, Herbert J, Ascherio A (2012) Increased risk of multiple sclerosis among women with migraine in the Nurses’ Health Study II. Mult Scler 18:90–7

Möhrke J, Kropp P, Zettl UK (2013) Headaches in multiple sclerosis patients might imply an inflammatorial process. PloS One 8: e69570

Graziano E, Hagemeier J, Weinstock-Guttman B, et al (2015) Increased contrast enhancing lesion activity in relapsingremitting multiple sclerosis migraine patients. Neuroimage Clin 9:110–6

Pöllmann W, Erasmus LP, Feneberg W, et al (2002) Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 59:636–9

Fragoso YD, Adoni T, Gomes S, et al (2015) Persistent headache in patients with multiple sclerosis starting treatment with fingolimod. Headache 55:578–9

Laroni A, Brogi D, Brescia Morra V, et al (2016) Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. Neurol Sci [in press]

Welch SP, Sim-Selley LJ, Selley DE (2012) Sphingosine-1-phosphate receptors as emerging targets for treatment of pain. Biochem Pharmacol 84:1551–62

Xu Z, Zhang F, Sun F, et al (2015) Dimethyl fumarate for multiple sclerosis. Cochrane Database Syst Rev 4):CD011076

Bernardini LR, Zecca C, Clerici VT, et al (2016) Severe articular and musculoskeletal pain: An unexpected side effect of dimethylfumarate therapy for multiple sclerosis. J Neurol Sci 369:139–40

Jawahar R, Oh U, Yang S, Lapane KL (2013) A systematic review of pharmacological pain management in multiple sclerosis. Drugs 73:1711–22

Solaro C, Trabucco E, Messmer Uccelli M (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr. Neurol. Neurosci Rep 13:320

Bouhassira D, Attal N, Alchaar H, et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36

Finnerup NB, Attal N, Haroutounian S, et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–73

Yadav V, Bever C, Bowen J, et al (2014) Summary of evidencebased guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology 82:1083–92

Solaro C, Messmer Uccelli M (2010) Pharmacological management of pain in patients with multiple sclerosis. Drugs 70:1245–54

Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629–808

Lanteri-Minet M, Valade D, Géraud G, et al (2013) [Guidelines for the diagnosis and management of migraine in adults and children]. Rev Neurol (Paris) 169:14–29

Moisset X, Mawet J, Guegan-Massardier E, et al (2016) French Guidelines For the Emergency Management of Headaches. Rev Neurol (Paris) 172:350–60

Bendtsen L, Evers S, Linde M, et al (2010) EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 17:1318–25

de Seze J, Borgel F, Brudon F (2012) Patient perceptions of multiple sclerosis and its treatment. Patient Prefer. Adherence 6:263–73

Ayache SS, Palm U, Chalah MA, et al (2016) Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis. Front. Neurosci 10:147

Moisset X, Goudeau S, Poindessous-Jazat F, et al (2015) Prolonged Continuous Theta-burst Stimulation is More Analgesic Than ‘Classical’ High Frequency Repetitive Transcranial Magnetic Stimulation. Brain Stimulat 8:135–41

Moisset X, de Andrade DC, Bouhassira D (2016) From pulses to pain relief: an update on the mechanisms of rTMS-induced analgesic effects. Eur J Pain 20:689–700